Wednesday 2 August 2023

Skin Excision Market Worth $59.0 Billion By 2030 | CAGR: 8.9%

 


The global Skin Excision Market size is expected to reach USD 59.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2022 to 2030. The market expansion of skin excision is primarily caused by the rising elderly population, rising obesity incidence, and rising aesthetic consciousness. The skin excision method has changed over a short period due to expanding demand, rising discretionary income, growing awareness, and adoption of cosmetic procedures, technological improvement in the devices used for surgeries, advancements in drugs and therapies, availability of qualified surgeons, and improved healthcare facilities.

Skin excision is a procedure in which excess skin is removal removed and people who lose a lot of weight through weight loss surgery or lifestyle changes opt for such treatment as their skin becomes loose and sags. There are various types of procedures for excess skin removal including Brachioplasty, Mastopexy, Rhytidectomy, Thigh lift, Neck Lift, Brow lift, Abdominoplasty, etc. These procedures are carried out at hospitals and clinics where board-certified surgeons perform such skin excision procedures.

People have become more conscious about their personalities and appearances with major influence from social media. To overcome body flaws because of aging, pregnancy, heredity, or high BMI, people opt for reconstructive surgeries. The ratio of females appearing for surgery seems to be higher than males. For instance, according to ISAPS report 2020, 92.0% of the total procedures of abdominoplasty (Tummy Tuck) were performed on females which were approximately 703,778 in number.

The demand for skin excision procedures shrank in 2020 due to the outbreak of COVID as global restrictions and lockdown were imposed in most countries initially, and many non-cosmetic surgical procedures were halted. However, ISAPS reported, that the willingness to opt for invasive as well as non-invasive treatments globally has increased post-pandemic.

Related Press Release@ Skin Excision Market Report

Skin Excision Market Report Highlights

  • By procedure type, the mastopexy segment held the largest revenue share in 2021 and is expected to witness a lucrative CAGR of over 9.4% from 2022 to 2030
  • Based on end-use, the clinics' segment dominated the market in 2021. The segment is expected to continue its dominance throughout the forecast period owing to the high preference for advanced devices and personalized services
  • North America dominated the market in 2021. The availability of experienced surgeons and high adoption rates for advanced technology are the factors that can be attributable to the high segment share
  • In the Asia Pacific, the market is expected to grow at a high rate during the forecast period during to the high awareness and adoption of cosmetic treatments

Related Reports@

Brachioplasty Market

Lip Augmentation Market

Skin Excision Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 29.9 billion

Revenue forecast in 2030

USD 59.0 billion

Growth Rate

CAGR of 8.9% from 2022 to 2030

Base year for estimation

2021

Historical data

2018 - 2020

Forecast period

2022 - 2030

 

Skin Excision Market Segmentation

Grand View Research has segmented the global skin excision market based on procedure type, end-use, and region:

Skin Excision Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Brachioplasty
  • Mastopexy
  • Rhytidectomy
  • Panniculectomy
  • Thigh Lift
  • Tummy Tuck
  • Neck Lift
  • Brow Lift
  • Breast Reduction

Skin Excision End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Clinics

Skin Excision Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players in the Skin Excision Market

  • Long Island Plastic Surgical Group, US
  • Nazarian Plastic Surgery, US
  • Charlotte: Piedmont Plastic Surgery & Dermatology, US
  • Bella Sante MD Cosmetic and Laser Clinic, Canada
  • American Hospital of Paris Plastic Surgery Unit, France

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Tuesday 1 August 2023

3D Printed Drugs Market by Aprecia; Formac Pharmaceuticals; Extend Biosciences; Affinity Therapeutics; Osmotica Pharmaceuticals

 


The global 3D Printed Drugs Market size is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.

An increase in the aging population has led to the growing demand for the development of easy-to-swallow pills for the elderly. The 3D printed highly soluble and easy-to-swallow drugs can help the elderly who have difficulty swallowing. Moreover, according to the United Nations, the number of people aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing elderly population across the world would propel the demand for easy-to-swallow drugs resulting in market growth.

Other factors such as quickly expanding demand for pharmaceuticals, technical improvements in healthcare, as well as the government's focus and expenditures in the 3D printing industry, are also contributing to the market's growth. For instance, in March 2022, Evonik Venture Capital invested in Nevada-based Laxxon Medical for the manufacturing of 3D-printed tablets. The latter company has developed a 3D screen-printing technology for the production of structured tablets with the controlled release of API over time. Such investments are likely to supplement the market growth in the coming years.

The COVID-19 pandemic is anticipated to positively impact market growth. Several printers have been launched by the operating companies in the advanced manufacturing industry to help increase the manufacturing of medications and other necessary products. As a result, the usage of these technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medicine is expected to majorly drive market growth in the coming years. As 3D printing of pharmaceutical drugs can produce personalized medicine in small batches with carefully tailored shapes, dosages, and sizes, the market is anticipated to grow at an exponential rate in the near future. In addition, the use of 3D printing technology can significantly reduce manufacturing costs thus, further increasing investments in this space.

On the other hand, adverse effects from these drugs, the use of 3D printing to create illegal drugs, and a lack of government restrictions for 3D printed products are limiting the market's growth. For instance, in March 2018, a police case was filed in Amsterdam, for the illegal handling of these drugs. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

Related Press Release@ 3D Printed Drugs Market Report

3D Printed Drugs Market Report Highlights

  • By technology, the zip dose segment held the largest share of the 3D market. This is attributed to the increase in the requirement for rapid soluble drugs that disperse quickly in the mouth, which in turn is likely to increase the adoption and anticipate market growth.
  • The inkjet printer segment is expected to grow lucratively during the forecast period. Due to the 3D medications can be personalized to each patient's needs, assisting them far more than batch-produced medicines, their demand is expected to skyrocket in the coming years.
  • By application, the neurology segment held a larger share of the global market. This is attributed to an increase in the proportion of older people, which is at an increased risk of developing neurological disorders and hence, propelling the market growth.
  • By end-use, the hospitals & clinics segment held a larger share in 2021, owing to the growing demand for personalized medicines and the cost-effective use of bio-drugs employing this technology.
  • North America dominated the global market in 2021 due to the availability of technologically advanced healthcare research framework, the presence of high R&D investment, and the development of 3D printed drugs in the region.
  • The Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of chronic diseases and the presence of key players.
  • A few of the key market players include 3D Printer Drug Machine, Aprecia Pharmaceuticals, BV LLC, Hewlett Packard Caribe, and others.

Related Category Reports@

Immunotherapy Drugs Market

Biomarkers Market

3D Printed Drugs Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 86.24 million

Revenue forecast in 2030

USD 269.74 million

Growth rate

CAGR of 15.32% from 2022 to 2030

Base year for estimation

2021

Historical data

2018 - 2020

Forecast period

2021 - 2030

 

3D Printed Drugs Market Segmentation

Grand View Research has segmented the global 3D printed drugs market based on technology, application, end-user, and region:

Technology Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Inkjet Printing
  • Fused Deposition Modeling
  • Stereolithography
  • ZipDose Technology

Application Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Orthopedic
  • Neurology
  • Dental
  • Others

End-use Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics
  • Research Laboratories
  • Others

Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Cellular Immunotherapy Market Worth $37.97 Billion By 2030

 




The global Cellular Immunotherapy Market size is expected to reach USD 37.97 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 22.41% during the forecast period, driven by the growing government support for innovative therapies research, rising prevalence of cancer, development of advanced cell-based immunotherapies, and increasing R&D investment by global players.

Growing support from government organizations and research institutes including the National Cancer Institute (NCI) and Center of Excellence in Immunology (CEI) for cellular immunotherapies research is one of the major factors driving the market growth. For instance, the CEI pulls out experts from other institutes such as NCI and NIH to promote the growth of immunotherapy for the treatment of cancer. Also, the Surgery Branch of the National Cancer Institute's Center for Cancer Research (CCR) is committed to the innovation of novel immunotherapies for the treatment of cancer patients.

The rising number of M&As, collaborations, acquisitions, and funding is a major trend observed in the market. M&A and collaboration help companies expand their existing product portfolio and regional reach in a short period. For instance, in March 2021, TrakCel received funding from Labcorp and AmerisourceBergen for cellular therapy orchestration research and global expansion. Also, in April 2020, Kite (a Gilead Company) and Teneobio, Inc. entered into a license agreement through which Kite will receive exclusive rights to specific antibodies targeted to B-cell maturation antigen (BCMA). Thus, such M&A and collaborations are expected to boost the market growth.

A substantial number of cellular immunotherapy companies are engaged in new product launches, pertaining to licensing, collaborations, & acquisitions, and regional expansion. Some of the key companies in the market are Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc. (Kite Pharma); F. Hoffmann-La Roche Ltd.; and Johnson & Johnson. These companies are adopting various business models to gain a competitive advantage. For instance, in February 2021, Novartis secured approval for the first Australian commercial CAR-T manufacturing site for Kymriah. With this approval, the company would be able to develop Kymriah in Australia, thereby providing easy access to Australian patients.

The COVID-19 pandemic has had a high impact on the market. Owing to stringent regulations to curb the pandemic, a slowdown in clinical trials, approval of new drugs, and delayed cancer diagnosis have been observed, affecting the industry's growth amid the pandemic. However, in several countries, the effect of COVID-19 declined after the third quarter of 2021, which helped the market regain traction.

Related Press Release@ Cellular Immunotherapy Market Report

List of Key Players in the Cellular Immunotherapy Market

  • Bristol-Myers Squibb Company
  • Novartis AG
  • Gilead Sciences Inc. (Kite Pharma)
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • Johnson & Johnson
  • Celyad
  • Adicet Bio, Inc.
  • Dendreon Pharmaceuticals LLC

Cellular Immunotherapy Market Report Highlights

  • CAR T cell therapy segment contributed a significant revenue share of 71.6% in 2021. Factors such as approval of new drugs, patent protection, and a robust product pipeline are expected to drive the segment
  • B-cell malignancy is the largest segment by indication in 2021 due to the high product penetration; BREYANZI and Yescarta are among the drugs that contribute to its high share
  • Hospitals dominated the market in 2021 due to the availability of skilled healthcare practitioners in hospital settings and ease of reimbursement
  • North America dominated the market in terms of revenue in 2021, owing to the availability of a well-established healthcare infrastructure, high per capita healthcare expenditure, and the increasing prevalence of cancer in the region
  • Some of the key players in the market space are Gilead Sciences Inc. (Kite Pharma); Bristol-Myers Squibb Company; Novartis AG; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc.; Merck KGaA; AstraZeneca; Celyad; Pfizer Inc.; Adicet Bio, Inc.; Johnson & Johnson; and Dendreon Pharmaceuticals LLC

Cellular Immunotherapy Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 7.5 billion

Revenue forecast in 2030

USD 37.97 billion

Growth Rate

CAGR of 22.41% from 2022 to 2030

Base year for estimation

2021

Historical data

2018 - 2020

Forecast period

2022 - 2030

 

Related Reports@

T-cell Therapy Market

Cell Therapy Market

Cellular Immunotherapy Market Segmentation

Grand View Research has segmented the global cellular immunotherapy market based on therapy type, indication, end-use, and region:

Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)

  • CAR T Cell Therapy
  • Dendritic Cell Therapy
  • NK Cell Therapy
  • TIL Therapy
  • Others

Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • B-cell Malignancies
  • Prostate Cancer
  • Liver Cancer
  • Renal Cell Carcinoma
  • Others

Cellular Immunotherapy End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Cancer Institutes
  • Others

Cellular Immunotherapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Digital Pathology Market Size To Reach $1.73 Billion By 2030

The global  Digital Pathology Market  size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, acco...